½ÃÀ庸°í¼­
»óǰÄÚµå
1781162

¼¼°èÀÇ ¼ö¸é º¸Á¶Á¦ ½ÃÀå : »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2025-2032³â)

Sleep Aids Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Persistence Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 185 Pages | ¹è¼Û¾È³» : 2-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Persistence Market Research´Â Àü ¼¼°è ¼ö¸é º¸Á¶Á¦ ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ º¸°í¼­´Â ½ÃÀå ±¸Á¶¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇϸç, ÃËÁø¿äÀÎ, µ¿Çâ, ±âȸ ¹× °úÁ¦¸¦ Æ÷ÇÔÇÑ Áß¿äÇÑ ½ÃÀå ¿ªÇп¡ ´ëÇÑ Ã¶ÀúÇÑ Æò°¡¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ ¿¬±¸ °£Ç๰Àº 2025³âºÎÅÍ 2032³â±îÁö Àü ¼¼°è ¼ö¸éÁ¦ ½ÃÀåÀÇ ¿¹»ó ¼ºÀå ±ËÀûÀ» ¿ä¾àÇÑ µ¶Á¡ÀûÀÎ µ¥ÀÌÅÍ¿Í Åë°è¸¦ Á¦°øÇÕ´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

  • ¼ö¸é º¸Á¶Á¦ ½ÃÀå ±Ô¸ð(2025³â) : 310¾ï ´Þ·¯
  • ½ÃÀå ±Ô¸ð ¿¹Ãø(±Ý¾× ±âÁØ, 2032³â) : 418¾ï ´Þ·¯
  • ¼¼°è ½ÃÀåÀÇ ¼ºÀå·ü(CAGR, 2025-2032³â) : 4.3%

¼ö¸é º¸Á¶Á¦ ½ÃÀå - ºÐ¼® ¹üÀ§

¼ö¸é º¸Á¶Á¦´Â ºÒ¸éÁõ, ¼ö¸é ¹«È£ÈíÁõ, ´Ù¸® ºÒ¾È ÁõÈıº, ±â¸éÁõ°ú °°Àº ¼ö¸é °ü·Ã Àå¾Ö¸¦ Ä¡·áÇϱâ À§ÇØ ¼³°èµÈ ´Ù¾çÇÑ Á¦Ç° ¹× Ä¡·á¹ýÀ» Æ÷ÇÔÇÕ´Ï´Ù. ¿©±â¿¡´Â 󹿾à, ÀÏ¹Ý ÀǾàǰ(OTC), ¾àÃÊ ¿ä¹ý, ¼ö¸é ±â±â ¹× Çൿ Ä¡·á µµ±¸°¡ Æ÷ÇԵ˴ϴÙ. ¼ö¸é º¸Á¶Á¦ ½ÃÀåÀº º´¿ø, ¼ö¸é Ŭ¸®´Ð, ÀçÅà °£È£ »ç¿ëÀÚ ¹× À£´Ï½º ¼¾Å͸¦ Æ÷ÇÔÇÑ ´Ù¾çÇÑ ÃÖÁ¾ »ç¿ëÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù. ½ÃÀå ¼ºÀåÀº ¼ö¸é °Ç°­¿¡ ´ëÇÑ ÀνÄÀÇ Áõ°¡, ¼ö¸é Àå¾ÖÀÇ ¹ß»ý·ü Áõ°¡, Á¤½Å °Ç°­¿¡ ´ëÇÑ ¿ì·ÁÀÇ Áõ°¡¿¡ ÀÇÇØ ÃßÁøµÇ°í ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ ¸ðµç ¿äÀεéÀº ¼±Áø±¹°ú °³¹ßµµ»ó±¹ ¸ðµÎ¿¡¼­ È¿°úÀûÀÎ ¼ö¸é ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ :

¼¼°èÀÇ ¼ö¸é º¸Á¶Á¦ ½ÃÀåÀº »ýȰ ¹æ½ÄÀÇ º¯È­, ½ºÆ®·¹½º ¼öÁØ Áõ°¡, °í·É Àα¸ Áõ°¡ µî ¼ö¸é °ü·Ã ¹®Á¦ÀÇ ±ÞÁõÀ» ÃÊ·¡ÇÏ´Â ¿©·¯ ¿äÀÎÀÇ Á¶ÇÕ¿¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ¼ö¸é ºÎÁ·ÀÌ Àü¹ÝÀûÀÎ °Ç°­, »ý»ê¼º ¹× ¸¸¼º ÁúȯÀÇ ¹ßº´¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó Áø´Ü ¹× Ä¡·á ºñÀ²ÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ½º¸¶Æ® ¼ö¸é ¸ð´ÏÅ͸µ Àåºñ ¹× AI ±â¹Ý ¼ö¸é ÃßÀû ½Ã½ºÅÛ µî ±â¼úÀû ¹ßÀüÀ¸·Î »ç¿ëÀÚ °æÇè°ú Ä¡·áÀÇ °³ÀÎÈ­°¡ ´õ¿í Çâ»óµÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, ÀüÀÚ »ó°Å·¡ Ç÷§ÆûÀÇ È®ÀåÀ¸·Î ƯÈ÷ ¿Üµý Áö¿ªÀ̳ª ¼­ºñ½º°¡ ºÎÁ·ÇÑ Áö¿ªÀÇ Àü ¼¼°è ¼ÒºñÀÚµéÀÌ ¼ö¸é º¸Á¶ Á¦Ç°À» ´õ ½±°Ô ÀÌ¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ :

À¯¸ÁÇÑ Àü¸Á¿¡µµ ºÒ±¸Çϰí, ¼ö¸é º¸Á¶Á¦ ½ÃÀåÀº ¾à¸®ÇÐÀû ¼ö¸é º¸Á¶Á¦ÀÇ Àå±â »ç¿ë°ú °ü·ÃµÈ ÀÇÁ¸¼º ¹× ºÎÀÛ¿ë¿¡ ´ëÇÑ ¿ì·Á¸¦ ºñ·ÔÇÑ ¿©·¯ °¡Áö ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ½Å¾à ½ÂÀο¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç°ú OTC Á¦Ç°¿¡ ´ëÇÑ ÁÖÀåµé¿¡ ´ëÇÑ °¨½Ã°¡ °­È­µÇ¸é¼­ Á¦Ç° Ãâ½Ã°¡ Áö¿¬µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼ö¸é Àå¾Ö Ä¡·á¿¡ ´ëÇÑ »çȸÀû Æí°ß°ú ÀϺΠÁö¿ªÀÇ Á¦ÇÑÀûÀÎ º¸Çè Àû¿ë Á¤Ã¥À¸·Î ÀÎÇØ, ƯÈ÷ Àú¼ÒµæÃþ¿¡¼­ ¼ö¸é °ü·Ã Ä¡·áÀÇ ÀÌ¿ëÀÌ ÀúÁ¶ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇÏ·Á¸é °ø°ø ±³À°, Áßµ¶¼ºÀÌ ¾ø´Â Ä¡·á¹ýÀÇ Çõ½Å, ±ÔÁ¦ ±â°ü°ú ÀÇ·á ¼­ºñ½º Á¦°øÀÚ °£ÀÇ Çù·ÂÀ» °­È­ÇÏ´Â µ¥ ÁýÁßÇØ¾ß ÇÕ´Ï´Ù.

½ÃÀå ±âȸ :

¿þ¾î·¯ºí ±â±â, ¾ÛÀÌ ÅëÇÕµÈ ºÒ¸éÁõ¿¡ ´ëÇÑ ÀÎÁö Çൿ Ä¡·á(CBT-I), õ¿¬ ¶Ç´Â Çãºê º¸ÃæÁ¦ µî °³ÀÎ ¸ÂÃãÇüÀÇ ºñħ½ÀÀû ¼ö¸é º¸Á¶ ±â±âÀÇ °³¹ß¿¡ Å« ±âȸ°¡ ÀÖ½À´Ï´Ù. µðÁöÅÐ °Ç°­ ±â¼ú°ú ¼ö¸é º¸Á¶ Á¦Ç°ÀÌ ÅëÇյǸé Àå±âÀûÀÎ ¸ð´ÏÅ͸µ, »ç¿ëÀÚ Áؼö ¹× ÀÓ»ó °á°ú°¡ Çâ»óµË´Ï´Ù. µµ½ÃÈ­¿Í »ýȰ ¹æ½ÄÀÇ º¯È­·Î ¼ö¸é Àå¾ÖÀÇ À¯º´·üÀÌ ³ô¾ÆÁö°í ÀÖ´Â ½ÅÈï ½ÃÀåÀº »õ·Î¿î ¼ºÀåÀÇ ÁöÆòÀ» Á¦½ÃÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀüüÀûÀÎ À£ºù¿¡ ´ëÇÑ °ü½ÉÀÇ Áõ°¡¿Í ¿¹¹æ ÀÇ·á·Î ÀüȯÀÌ ÀÚ¿¬½º·´°í º¸¿ÏÀûÀÎ ¼ö¸é ¼Ö·ç¼ÇÀÇ ±æÀ» ¿­¾îÁÖ°í ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´äº¯À» ¾òÀ» ¼ö ÀÖ´Â ÁÖ¿ä Áú¹®

  • ¼¼°èÀÇ ¼ö¸é º¸Á¶Á¦ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖµÈ ¿äÀÎÀº ¹«¾ùÀΰ¡?
  • ¼ö¸é º¸Á¶Á¦ ºÐ¾ß¿¡¼­ ¼ÒºñÀÚÀÇ ±âÈ£¸¦ Çü¼ºÇϰí ÀÖ´Â Á¦Ç° Ä«Å×°í¸®¿Í À¯Åë ä³ÎÀº ¹«¾ùÀΰ¡?
  • µðÁöÅÐ ±â¼úÀ̳ª ¿þ¾î·¯ºí ±â¼úÀº Ä¡·á µµÀÔÀ̳ª »ç¿ëÀÚ Çൿ¿¡ ¾î¶² ¿µÇâÀ» ÁÖ°í Àִ°¡?
  • ¼ö¸é º¸Á¶Á¦ ¼¼°è ½ÃÀå¿¡ À־ÀÇ ÁÖ¿ä ±â¾÷Àº ¾î´À °Í, ¶Ç ½ÃÀå È®´ë¸¦ À§ÇØ ¾î¶°ÇÑ Àü·«À» äÅÃÇϰí Àִ°¡?
  • ¼ö¸é º¸Á¶Á¦ ¾÷°èÀÇ »õ·Î¿î µ¿Çâ°ú Àå±âÀû Àü¸ÁÀº?

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

  • ½ÃÀåÀÇ ¹üÀ§¿Í Á¤ÀÇ
  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
    • ÁÖ¿ä µ¿Çâ
  • °Å½Ã°æÁ¦ ¿äÀÎ
    • ¼¼°èÀÇ ¼½Åͺ° Àü¸Á
    • ¼¼°èÀÇ GDP ¼ºÀå Àü¸Á
  • COVID-19ÀÇ ¿µÇ⠺м®
  • ¿¹Ãø ¿äÀÎ : °ü·Ã¼º°ú ¿µÇâ

Á¦3Àå ºÎ°¡°¡Ä¡ ºÐ¼®

  • ±ÔÁ¦ »óȲ
  • ÆÄÀÌÇÁ¶óÀÎ ºÐ¼®
  • Á¦Ç° äÅà ºÐ¼®
  • ¹ë·ùüÀÎ ºÐ¼®
  • Á¦Á¶¾÷üÀÇ ÁÖ¿ä ÇÁ·Î¸ð¼Ç Àü·«
  • PESTLE ºÐ¼®
  • Porter's Five Forces ºÐ¼®

Á¦4Àå ¼ö¸é º¸Á¶Á¦ ½ÃÀå Àü¸Á

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
    • ½ÃÀå ±Ô¸ð¿Í Àü³â´ëºñ ¼ºÀå·ü(±Ý¾× ±âÁØ)
    • Àý´ë ¼öÀÍ ±âȸ
  • ½ÃÀå ±Ô¸ðÀÇ ºÐ¼®°ú ¿¹Ãø(±Ý¾× ±âÁØ)
    • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼®(±Ý¾× ±âÁØ, 2019-2024³â)
    • ÇöÀç ½ÃÀå ±Ô¸ðÀÇ ºÐ¼®°ú ¿¹Ãø(±Ý¾× ±âÁØ, 2025-2032³â)
  • ¼¼°èÀÇ ¼ö¸é º¸Á¶Á¦ ½ÃÀå Àü¸Á : Á¦Ç°º°
    • ¼Ò°³ ¹× ÁÖ¿ä ºÐ¼® °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : Á¦Ç°º°(±Ý¾× ±âÁØ, 2019-2024³â)
    • ½ÃÀå ±Ô¸ðÀÇ ºÐ¼®°ú ¿¹Ãø : Á¦Ç°º°(±Ý¾× ±âÁØ, 2025-2032³â)
      • ¸ÅÆ®¸®½º ¹× º£°³
      • ÀǾàǰ
      • ¼ö¸é ¹«È£ÈíÁõ Ä¡·á Àåºñ
      • ±âŸ
    • ½ÃÀå ¸Å·Â ºÐ¼® : Á¦Ç°º°
  • ¼¼°èÀÇ ¼ö¸é º¸Á¶Á¦ ½ÃÀå Àü¸Á : ¼ö¸é Àå¾Öº°
    • ¼Ò°³ ¹× ÁÖ¿ä ºÐ¼® °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : ¼ö¸é Àå¾Öº°(±Ý¾× ±âÁØ, 2019-2024³â)
    • ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ¼ö¸é Àå¾Öº°(±Ý¾× ±âÁØ, 2025-2032³â)
      • ºÒ¸éÁõ
      • ¼ö¸é ¹«È£ÈíÁõ
      • ´Ù¸® ºÒ¾È ÁõÈıº
      • ³ª¸£ÄÝ·¹ÇÁ½Ã
      • ±â¸éÁõ
      • ±âŸ ¼ö¸éÀå¾Ö
    • ½ÃÀå ¸Å·Â ºÐ¼® : ¼ö¸éÀå¾Öº°

Á¦5Àå ¼¼°èÀÇ ¼ö¸é º¸Á¶Á¦ ½ÃÀå Àü¸Á : Áö¿ªº°

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : Áö¿ªº°(±Ý¾× ±âÁØ, 2019-2024³â)
  • ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : Áö¿ªº°(±Ý¾× ±âÁØ, 2025-2032³â)
    • ºÏ¹Ì
    • À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ³²¾Æ½Ã¾Æ¿Í ¿À¼¼¾Æ´Ï¾Æ
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ½ÃÀå ¸Å·Â ºÐ¼® : Áö¿ª

Á¦6Àå ºÏ¹ÌÀÇ ¼ö¸é º¸Á¶Á¦ ½ÃÀå Àü¸Á :

Á¦7Àå À¯·´ÀÇ ¼ö¸é º¸Á¶Á¦ ½ÃÀå Àü¸Á :

Á¦8Àå µ¿¾Æ½Ã¾ÆÀÇ ¼ö¸é º¸Á¶Á¦ ½ÃÀå Àü¸Á :

Á¦9Àå ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾ÆÀÇ ¼ö¸é º¸Á¶Á¦ ½ÃÀå Àü¸Á :

Á¦10Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ¼ö¸é º¸Á¶Á¦ ½ÃÀå Àü¸Á :

Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¼ö¸é º¸Á¶Á¦ ½ÃÀå Àü¸Á :

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2025³â)
  • ½ÃÀå ±¸Á¶
    • °æÀï °­µµ ¸Ê : ½ÃÀ庰
    • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ(»ó¼¼ : °³¿ä, À繫, Àü·«, ÃÖ±Ù µ¿Çâ)
    • Biodiem
    • AstraZeneca Plc
    • Cadwell Industries Inc.
    • Compumedics Limited
    • CSL Limited
    • GlaxoSmithKline Plc.
    • Eisai Co., Ltd.
    • Emergent Biosolutions
    • Merck and Co. Inc.
    • SleepMed Inc.

Á¦13Àå ºÎ·Ï

  • ºÐ¼® ¹æ¹ý
  • ºÐ¼®ÀÇ ÀüÁ¦
  • µÎÀÚ¾î ¹× ¾à¾î
HBR 25.08.07

Persistence Market Research has recently released a comprehensive report on the worldwide market for sleep aids. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global sleep aids market from 2025 to 2032.

Key Insights:

  • Sleep Aids Market Size (2025E): USD 31 Billion
  • Projected Market Value (2032F): USD 41.8 Billion
  • Global Market Growth Rate (CAGR 2025 to 2032): 4.3%

Sleep Aids Market - Report Scope:

Sleep aids encompass a broad spectrum of products and therapies designed to treat sleep-related disorders such as insomnia, sleep apnea, restless leg syndrome, and narcolepsy. These include prescription medications, over-the-counter (OTC) drugs, herbal remedies, sleep devices, and behavioral therapy tools. The sleep aids market caters to a diverse range of end users, including hospitals, sleep clinics, home care users, and wellness centers. Market growth is propelled by increasing awareness of sleep health, rising incidences of sleep disorders, and growing mental health concerns, all contributing to a higher demand for effective sleep solutions across both developed and developing economies.

Market Growth Drivers:

The global sleep aids market is driven by a combination of lifestyle changes, increasing stress levels, and a growing elderly population-all contributing to a surge in sleep-related issues. The growing recognition of the impact of poor sleep on overall health, productivity, and chronic disease development has led to higher rates of diagnosis and treatment. Technological advancements, including smart sleep monitoring devices and AI-powered sleep tracking systems, have further enhanced user experience and treatment personalization. Additionally, the expansion of e-commerce platforms has made sleep aid products more accessible to a global consumer base, especially in remote or underserved areas.

Market Restraints:

Despite a promising outlook, the sleep aids market faces several challenges, including concerns about dependency and side effects associated with long-term use of pharmacological sleep aids. Stringent regulatory requirements for new drug approvals and the growing scrutiny over OTC product claims hinder rapid product introduction. Moreover, social stigma around seeking treatment for sleep disorders and limited reimbursement policies in some regions reduce the uptake of sleep-related therapies, especially among lower-income groups. Addressing these issues requires a focus on public education, innovation in non-addictive therapies, and greater collaboration between regulatory bodies and healthcare providers.

Market Opportunities:

Significant opportunities lie in the development of personalized and non-invasive sleep aids, such as wearable devices, app-integrated cognitive behavioral therapy for insomnia (CBT-I), and natural or herbal supplements. The integration of digital health technologies with sleep aid products enhances long-term monitoring, user compliance, and clinical outcomes. Emerging markets, where urbanization and lifestyle changes are leading to a higher prevalence of sleep disorders, present new growth frontiers. Furthermore, the rising interest in holistic wellness and the shift toward preventive healthcare open avenues for natural and complementary sleep solutions.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the global sleep aids market?
  • Which product categories and distribution channels are shaping consumer preferences in the sleep aids space?
  • How are digital and wearable technologies influencing treatment adoption and user behavior?
  • Who are the leading players in the global sleep aids market, and what strategies are they adopting for market expansion?
  • What are the emerging trends and long-term prospects in the sleep aids industry?

Competitive Intelligence and Business Strategy:

These firms invest in the development of advanced formulations, non-drug therapies, and connected sleep devices to address various consumer needs. Collaborations with telehealth providers, pharmacies, and research institutions enhance product outreach and clinical validation. Furthermore, awareness campaigns and sleep health education programs help destigmatize treatment-seeking behavior and reinforce brand loyalty in a growing market.

Key Companies Profiled:

  • AstraZeneca Plc
  • Biodiem
  • Cadwell Industries Inc.
  • Compumedics Limited
  • CSL Limited
  • GlaxoSmithKline Plc.
  • Eisai Co., Ltd.
  • Emergent Biosolutions
  • Merck and Co. Inc.
  • SleepMed Inc.

Sleep Aids Market Research Segmentation:

The sleep aids market encompasses a wide range of products, applications, and end-user segments, addressing the multifaceted nature of sleep disorders and their treatment.

By Product

  • Mattresses & Pillows
  • Medications
  • Sleep Apnea Devices
  • Others

By Sleep Disorder

  • Insomnia
  • Sleep Apnea
  • Restless Legs Syndrome
  • Narcolepsy
  • Sleepwalking
  • Other Sleep Disorders

By Region

  • North America
  • Europe
  • Asia Pacific
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Sleep Aids Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Regulatory Landscape
  • 3.2. Pipeline Analysis
  • 3.3. Product Adoption Analysis
  • 3.4. Value Chain Analysis
  • 3.5. Key Promotional Strategies by Manufacturers
  • 3.6. PESTLE Analysis
  • 3.7. Porter's Five Force Analysis

4. Sleep Aids Market Outlook:

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
    • 4.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 4.3. Global Sleep Aids Market Outlook: Product
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Product, 2019-2024
    • 4.3.3. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
      • 4.3.3.1. Mattresses & Pillows
      • 4.3.3.2. Medications
      • 4.3.3.3. Sleep Apnea Devices
      • 4.3.3.4. Others
    • 4.3.4. Market Attractiveness Analysis: Product
  • 4.4. Global Sleep Aids Market Outlook: Sleep Disorder
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Bn) Analysis, By Sleep Disorder, 2019-2024
    • 4.4.3. Market Size (US$ Bn) Analysis and Forecast, By Sleep Disorder, 2025-2032
      • 4.4.3.1. Insomnia
      • 4.4.3.2. Sleep Apnea
      • 4.4.3.3. Restless Legs Syndrome
      • 4.4.3.4. Narcolepsy
      • 4.4.3.5. Sleepwalking
      • 4.4.3.6. Other Sleep Disorders
    • 4.4.4. Market Attractiveness Analysis: Sleep Disorder

5. Global Sleep Aids Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
  • 5.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Sleep Aids Market Outlook:

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 6.2.1. By Product
    • 6.2.2. By Sleep Disorder
  • 6.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
    • 6.4.1. Mattresses & Pillows
    • 6.4.2. Medications
    • 6.4.3. Sleep Apnea Devices
    • 6.4.4. Others
  • 6.5. Market Size (US$ Bn) Analysis and Forecast, By Sleep Disorder, 2025-2032
    • 6.5.1. Insomnia
    • 6.5.2. Sleep Apnea
    • 6.5.3. Restless Legs Syndrome
    • 6.5.4. Narcolepsy
    • 6.5.5. Sleepwalking
    • 6.5.6. Other Sleep Disorders
  • 6.6. Market Attractiveness Analysis

7. Europe Sleep Aids Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Sleep Disorder
  • 7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
    • 7.4.1. Mattresses & Pillows
    • 7.4.2. Medications
    • 7.4.3. Sleep Apnea Devices
    • 7.4.4. Others
  • 7.5. Market Size (US$ Bn) Analysis and Forecast, By Sleep Disorder, 2025-2032
    • 7.5.1. Insomnia
    • 7.5.2. Sleep Apnea
    • 7.5.3. Restless Legs Syndrome
    • 7.5.4. Narcolepsy
    • 7.5.5. Sleepwalking
    • 7.5.6. Other Sleep Disorders
  • 7.6. Market Attractiveness Analysis

8. East Asia Sleep Aids Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Sleep Disorder
  • 8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
    • 8.4.1. Mattresses & Pillows
    • 8.4.2. Medications
    • 8.4.3. Sleep Apnea Devices
    • 8.4.4. Others
  • 8.5. Market Size (US$ Bn) Analysis and Forecast, By Sleep Disorder, 2025-2032
    • 8.5.1. Insomnia
    • 8.5.2. Sleep Apnea
    • 8.5.3. Restless Legs Syndrome
    • 8.5.4. Narcolepsy
    • 8.5.5. Sleepwalking
    • 8.5.6. Other Sleep Disorders
  • 8.6. Market Attractiveness Analysis

9. South Asia & Oceania Sleep Aids Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Sleep Disorder
  • 9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
    • 9.4.1. Mattresses & Pillows
    • 9.4.2. Medications
    • 9.4.3. Sleep Apnea Devices
    • 9.4.4. Others
  • 9.5. Market Size (US$ Bn) Analysis and Forecast, By Sleep Disorder, 2025-2032
    • 9.5.1. Insomnia
    • 9.5.2. Sleep Apnea
    • 9.5.3. Restless Legs Syndrome
    • 9.5.4. Narcolepsy
    • 9.5.5. Sleepwalking
    • 9.5.6. Other Sleep Disorders
  • 9.6. Market Attractiveness Analysis

10. Latin America Sleep Aids Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Sleep Disorder
  • 10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
    • 10.4.1. Mattresses & Pillows
    • 10.4.2. Medications
    • 10.4.3. Sleep Apnea Devices
    • 10.4.4. Others
  • 10.5. Market Size (US$ Bn) Analysis and Forecast, By Sleep Disorder, 2025-2032
    • 10.5.1. Insomnia
    • 10.5.2. Sleep Apnea
    • 10.5.3. Restless Legs Syndrome
    • 10.5.4. Narcolepsy
    • 10.5.5. Sleepwalking
    • 10.5.6. Other Sleep Disorders
  • 10.6. Market Attractiveness Analysis

11. Middle East & Africa Sleep Aids Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Sleep Disorder
  • 11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
    • 11.4.1. Mattresses & Pillows
    • 11.4.2. Medications
    • 11.4.3. Sleep Apnea Devices
    • 11.4.4. Others
  • 11.5. Market Size (US$ Bn) Analysis and Forecast, By Sleep Disorder, 2025-2032
    • 11.5.1. Insomnia
    • 11.5.2. Sleep Apnea
    • 11.5.3. Restless Legs Syndrome
    • 11.5.4. Narcolepsy
    • 11.5.5. Sleepwalking
    • 11.5.6. Other Sleep Disorders
  • 11.6. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Biodiem
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. AstraZeneca Plc
    • 12.3.3. Cadwell Industries Inc.
    • 12.3.4. Compumedics Limited
    • 12.3.5. CSL Limited
    • 12.3.6. GlaxoSmithKline Plc.
    • 12.3.7. Eisai Co., Ltd.
    • 12.3.8. Emergent Biosolutions
    • 12.3.9. Merck and Co. Inc.
    • 12.3.10. SleepMed Inc.

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦